Skip to content

Research on Protein Metabolism Regulatory Networks in First-Episode Schizophrenia Patients with Suicidal Ideation

Research on Protein Metabolism Regulatory Networks in First-Episode Schizophrenia Patients with Suicidal Ideation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128813
Enrollment
Unknown
Registered
2026-07-27
Start date
2026-07-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

First onset schizophrenia with suicidal ideation

Interventions

case group:None
Healthy control group:None

Sponsors

The Second General Hospital of Fuzhou Neuropsychiatric prevention and treatment Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Age range: 18-60 years old; 2.Patients with schizophrenia who meet the diagnosis criteria of the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V), shall be diagnosed by two psychiatrists with the title of attending physician or above in our hospital; 3.A score of 1 in either item 4 or item 5 of the Chinese version of the Beck's Suicidal Ideation Inventory (BSI-CV) indicates the presence of suicidal ideation; 4.Not receiving antipsychotic or antidepressant medication treatment, experiencing a first episode;

Exclusion criteria

Exclusion criteria: 1.The disease diagnosis is consistent with other mental disorders in DSM-V, such as mental retardation, depression, etc; 2.Combined with severe infections or other serious physical illnesses (such as heart, liver, kidney dysfunction, cancer, etc.); 3.Combined substance abuse (excluding smoking and alcohol consumption); 4.Medical history and family history of metabolic related diseases such as diabetes and autoimmune diseases; 5.Being pregnant or breastfeeding;

Design outcomes

Primary

MeasureTime frame
differentially expressed protein;differential metabolite;

Countries

China

Contacts

Public ContactJiawu Ji

The Second General Hospital of Fuzhou Neuropsychiatric prevention and treatment Hospital

820845861@qq.com+86 591 6306 9551

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026